Your browser doesn't support javascript.
loading
Ureaplasma and Mycoplasma Screening for Pregnant Individuals Who Are at High Risk for Preterm Birth.
Kawakita, Tetsuya; Waller, Jerri; DeYoung, Tracey; Nehme, Lea; Collazo, Madison C; Barake, Carole; Ethirajan, Monica A; Kanaan, Camille M; Abuhamad, Alfred.
Afiliação
  • Kawakita T; Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia.
  • Waller J; Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia.
  • DeYoung T; Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia.
  • Nehme L; Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia.
  • Collazo MC; Department of Obstetrics and Gynecology, Inova Fairfax Hospital, Falls Church, Virginia.
  • Barake C; Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas.
  • Ethirajan MA; Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia.
  • Kanaan CM; Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia.
  • Abuhamad A; Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia.
Am J Perinatol ; 2023 Jul 29.
Article em En | MEDLINE | ID: mdl-37516118
ABSTRACT

OBJECTIVE:

This study aimed to examine gestational age at delivery according to Ureaplasma/Mycoplasma cervical culture results and whether pregnant individuals received antibiotics. STUDY

DESIGN:

A retrospective cohort study at a single academic institution where all pregnant individuals with risk factors for preterm birth including those with a history of preterm birth, recurrent pregnancy loss, or pregnancy requiring cervical cerclage were included. We plotted Kaplan-Meier curves to investigate the association between the gestational age at delivery and Ureaplasma culture results (negative; positive and treated; or positive but did not receive the treatment). A Cox proportional regression model was used to calculate hazard ratio (HR) with 95% confidence intervals (95% CI), controlling for confounders. The main outcome was age at delivery. Analyses were repeated for Mycoplasma culture.

RESULTS:

Of 607 individuals, 258 (42.5%) had a negative Ureaplasma culture, 308 (50.7%) had a positive Ureaplasma culture and received treatment, and 41 (6.8%) had a positive Ureaplasma culture and did not receive treatment. Compared with those who had a positive Ureaplasma culture but did not receive treatment, those who had a negative Ureaplasma culture did not have a decreased risk (HR 1.03; 95% CI 0.74-1.44). Compared with those who had a positive Ureaplasma culture but did not receive treatment, those who had a positive Ureaplasma culture and received treatment did not have a decreased risk (HR 0.91; 95% CI 0.66-1.27). The treatment failure rate of Ureaplasma after treatment was 78.6% (95% CI 72.8-83.7%). Overall, the findings of Mycoplasma were similar.

CONCLUSION:

Routine ureaplasma/mycoplasma cervical culture is not recommended for pregnant individuals who are at high risk for preterm birth. KEY POINTS · Ureaplasma/mycoplasma species are isolated in patients with preterm birth.. · High ureaplasma/mycoplasma recurrence rate despite treatment with antibiotics.. · Treatment of patient and partner did not improve gestational age at delivery..

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Am J Perinatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Am J Perinatol Ano de publicação: 2023 Tipo de documento: Article